| Biotech/Medical Technology Stock News; Aethlon Medical (OTCBB: AEMD ... - Pressitt (press release) |
|
|
Pressitt (press release) The ADAPT System is an adaptive dialysis-like affinity platform technology that provides a novel and potentially expedited commercialization pathway for monoclonal antibodies and other affinity drug agents. The platform technology allows for single or |